J.P. Morgan Sees GLP-1 Market in China, India and Brazil Reaching $22 Billion by 2035

J.P. Morgan estimates the combined weight-loss drug market in China, India and Brazil could grow to $22 billion by 2035 from $6.6 billion currently, driven by improving affordability and broader access.